69677 Sigma-AldrichpET-19b DNA - Novagen
Novagen's pET-19b vector carries an N-terminal His•Tag® sequence followed by an enterokinase cleavage site and three cloning sites.
More>> Novagen's pET-19b vector carries an N-terminal His•Tag® sequence followed by an enterokinase cleavage site and three cloning sites. Less<<pET-19b DNA - Novagen: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.
Prodotti consigliati
-
ABN1365 Sigma-Aldrich Anti-OSTM1 -
NY1002500 Millipore Filtri a rete in Nylon, idrofili, 10 µm, 25 mm -
150454 Supelco SeQuant® ZIC®-HILIC 5µm,200Å 150 x 2.1 mm -
ZWBASE012 Milli-Q ROCare B -
LCWP14250 Millipore Filtri a membrana Mitex, PTFE, idrofobi, 10 µm, 142 mm, bianchi, piani -
AB707-K Sigma-Aldrich Goat Anti-Human Alpha-1-Antitrypsin (1mL) -
8102980100 Sigma-Aldrich Benziltrietilammonio cloruro -
GR32L-100UG Sigma-Aldrich Anti-Glucocorticoid Receptor (Ab-2) Mouse mAb (BuGR2) -
CBL1512F Sigma-Aldrich Anti-Integrin αM [CD11b] Antibody, clone OX-42, FITC conjugated -
MAB4383 Sigma-Aldrich Anti-Nuclei Antibody, clone 3E1.3
Panoramica
Prezzi e disponibilità
| Numero di catalogo | Disponibilità | Confezionamento | Qtà/conf | Prezzo | Quantità | |
|---|---|---|---|---|---|---|
| 69677-3 |
|
Fiala di plastica | 10 μg |
|
— |
| Description | |
|---|---|
| Overview | The pET-19b vector carries an N-terminal His•Tag® sequence followed by
an enterokinase cleavage site and three cloning sites. Note that the sequence is numbered by the pBR322 convention, so the T7 expression region is reversed on the vector map (TB049). The pET Vectors are supplied as purified plasmid DNA (10 µg). Each order of pET DNA also includes an Induction Control strain (supplied as a glycerol stock). Please contact technical service if you need additional information. This product is sold for internal research use only. Any commercial use of this product, its components, and/or any derivatives thereof (including but not limited to proteins produced using the product or its components) (together and hereinafter the 'EMD Product') requires signature of a written commercial use agreement with EMD Millipore Corporation or its successor-in-interest. Commercial use shall include but not be limited to: (1) use of the EMD Product to manufacture products for sale to third parties; (2) use of the EMD Product to provide services, information, or data to third parties in exchange for consideration; (3) use of the EMD Product for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the EMD Product, whether or not such EMD Product is resold for research use. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of the EMD Product. Please direct any questions on these use restrictions to: licensing@milliporesigma.com. |
| This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges MilliporeSigma to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form. | |
| Catalogue Number | 69677 |
| Brand Family | Novagen® |
| Product Information | |
|---|---|
| Quality Level | MQ100 |
| Storage and Shipping Information | |
|---|---|
| Ship Code | Shipped with Blue Ice or with Dry Ice |
| Toxicity | Standard Handling |
| Storage | ≤ -70°C |
| Avoid freeze/thaw | Avoid freeze/thaw |
| Do not freeze | Ok to freeze |
| Global Trade Item Number | |
|---|---|
| Numero di catalogo | GTIN |
| 69677-3 | 04055977258950 |